CSF-1R inhibitor BLZ945, Purity ≥98%

Cat. No.: X24-06-ZQ396

CSF-1R inhibitor BLZ945, Purity ≥98%

Synonym: 953769-46-5; CSF-1R inhibitor; BLZ 945; BLZ-945

  • MDL: MFCD28142668
  • CAS Number: 953769-46-5
  • Compound CID: 46184986
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BLZ945, soluble in DMSO and warmed ethanol and insoluble in water, inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets CSF-1R.
Molecular Weight
398.4
Molecular Formula
C20H22N4O3S
Targets
CSF-1R: 1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 77 mg/mL (193.23 mM); Water: Insoluble; Warmed ethanol: 3 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
BLZ945 is used to investigate macrophage-related mechanisms in cancer and inflammatory research, highlighting its therapeutic potential.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0